Your browser doesn't support javascript.
loading
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.
Kamoun, A; Cancel-Tassin, G; Fromont, G; Elarouci, N; Armenoult, L; Ayadi, M; Irani, J; Leroy, X; Villers, A; Fournier, G; Doucet, L; Boyault, S; Brureau, L; Multigner, L; Diedhiou, A; Roupret, M; Compérat, E; Blanchet, P; de Reyniès, A; Cussenot, O.
Afiliação
  • Kamoun A; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France. Electronic address: aurelie.kamoun@ligue-cancer.net.
  • Cancel-Tassin G; Research Center for Prostatic Pathologies (CeRePP), Paris, France; Clinical Research Group n°5, ONCOTYPE-URO, Pierre and Marie Curie University, Paris, France.
  • Fromont G; Research Center for Prostatic Pathologies (CeRePP), Paris, France; Department of Pathology, Tours University Hospital, Tours, France.
  • Elarouci N; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Armenoult L; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Ayadi M; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Irani J; Department of Urology, Miletrie Hospital, Poitiers, France.
  • Leroy X; Department of Pathology, Lille University Research Hospital, Lille, France.
  • Villers A; Department of Urology, Lille University Research Hospital, Lille, France.
  • Fournier G; Department of Urology, Cavale Blanche Hospital, Brest, France.
  • Doucet L; Department of Pathology, Cavale Blanche Hospital, Brest, France.
  • Boyault S; Department of Translational Research and Cancers Genomic Innovation Department, Synergie Lyon Cancer Foundation, Lyon, France.
  • Brureau L; Department of Urology, Pointe-à-Pitre/Abymes University Hospital, Pointe-à-Pitre, Guadeloupe, France; Inserm U1085 - IRSET, Rennes, France.
  • Multigner L; Inserm U1085 - IRSET, Rennes, France.
  • Diedhiou A; Department of Pathology, Pointe-à-Pitre/Abymes University Hospital, Pointe-à-Pitre, Guadeloupe (French West Indies), France.
  • Roupret M; Research Center for Prostatic Pathologies (CeRePP), Paris, France; Clinical Research Group n°5, ONCOTYPE-URO, Pierre and Marie Curie University, Paris, France; Department of Urology, Pitié-Salpêtrière Hospital, Paris, France.
  • Compérat E; Research Center for Prostatic Pathologies (CeRePP), Paris, France; Clinical Research Group n°5, ONCOTYPE-URO, Pierre and Marie Curie University, Paris, France; Department of Pathology, Tenon Hospital, Paris, France.
  • Blanchet P; Department of Urology, Pointe-à-Pitre/Abymes University Hospital, Pointe-à-Pitre, Guadeloupe, France; Inserm U1085 - IRSET, Rennes, France.
  • de Reyniès A; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Cussenot O; Research Center for Prostatic Pathologies (CeRePP), Paris, France; Clinical Research Group n°5, ONCOTYPE-URO, Pierre and Marie Curie University, Paris, France; Department of Urology, Tenon Hospital, Paris, France.
Ann Oncol ; 29(8): 1814-1821, 2018 08 01.
Article em En | MEDLINE | ID: mdl-29945238

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Biomarcadores Tumorais / Seleção de Pacientes Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Biomarcadores Tumorais / Seleção de Pacientes Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
...